These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 19726673

  • 1. Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage.
    Myette JR, Soundararajan V, Behr J, Shriver Z, Raman R, Sasisekharan R.
    J Biol Chem; 2009 Dec 11; 284(50):35189-200. PubMed ID: 19726673
    [Abstract] [Full Text] [Related]

  • 2. Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity.
    Myette JR, Soundararajan V, Shriver Z, Raman R, Sasisekharan R.
    J Biol Chem; 2009 Dec 11; 284(50):35177-88. PubMed ID: 19726671
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular cloning of the heparin/heparan sulfate delta 4,5 unsaturated glycuronidase from Flavobacterium heparinum, its recombinant expression in Escherichia coli, and biochemical determination of its unique substrate specificity.
    Myette JR, Shriver Z, Kiziltepe T, McLean MW, Venkataraman G, Sasisekharan R.
    Biochemistry; 2002 Jun 11; 41(23):7424-34. PubMed ID: 12044176
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Examination of the substrate specificity of heparin and heparan sulfate lyases.
    Linhardt RJ, Turnbull JE, Wang HM, Loganathan D, Gallagher JT.
    Biochemistry; 1990 Mar 13; 29(10):2611-7. PubMed ID: 2334685
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.
    Nader HB, Kobayashi EY, Chavante SF, Tersariol IL, Castro RA, Shinjo SK, Naggi A, Torri G, Casu B, Dietrich CP.
    Glycoconj J; 1999 Jun 13; 16(6):265-70. PubMed ID: 10579695
    [Abstract] [Full Text] [Related]

  • 10. Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate.
    Shaya D, Zhao W, Garron ML, Xiao Z, Cui Q, Zhang Z, Sulea T, Linhardt RJ, Cygler M.
    J Biol Chem; 2010 Jun 25; 285(26):20051-61. PubMed ID: 20404324
    [Abstract] [Full Text] [Related]

  • 11. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
    Guglier S, Hricovíni M, Raman R, Polito L, Torri G, Casu B, Sasisekharan R, Guerrini M.
    Biochemistry; 2008 Dec 30; 47(52):13862-9. PubMed ID: 19117094
    [Abstract] [Full Text] [Related]

  • 12. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
    Loo BM, Kreuger J, Jalkanen M, Lindahl U, Salmivirta M.
    J Biol Chem; 2001 May 18; 276(20):16868-76. PubMed ID: 11278860
    [Abstract] [Full Text] [Related]

  • 13. New oligosaccharides from heparin and heparan sulfate and their use as substrates for heparin-degrading enzymes.
    Reynertson R, Campbell P, Ford JD, Jacobsson I, Rodén L, Thompson JN.
    J Biol Chem; 1983 Jun 25; 258(12):7449-59. PubMed ID: 6223028
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Opposite effects of basic fibroblast growth factor and heparin on heparin/heparan sulfate degrading enzymes from Flavobacterium heparinum.
    Cavari S, Vannucchi S.
    Biochem Mol Biol Int; 1996 Jul 25; 39(4):823-31. PubMed ID: 8843352
    [Abstract] [Full Text] [Related]

  • 16. Role of arginine 292 in the catalytic activity of chondroitin AC lyase from Flavobacterium heparinum.
    Capila I, Wu Y, Rethwisch DW, Matte A, Cygler M, Linhardt RJ.
    Biochim Biophys Acta; 2002 Jun 03; 1597(2):260-70. PubMed ID: 12044904
    [Abstract] [Full Text] [Related]

  • 17. Characterization of annexin A1 glycan binding reveals binding to highly sulfated glycans with preference for highly sulfated heparan sulfate and heparin.
    Horlacher T, Noti C, de Paz JL, Bindschädler P, Hecht ML, Smith DF, Fukuda MN, Seeberger PH.
    Biochemistry; 2011 Apr 05; 50(13):2650-9. PubMed ID: 21370880
    [Abstract] [Full Text] [Related]

  • 18. New pathway of heparan sulphate degradation. Iduronate sulphatase and N-sulphoglucosamine 6-sulphatase act on the polymer chain prior to depolymerisation by a N-sulpho-glucosaminidase and glycuronidases in the mollusc Tagelus gibbus.
    Medeiros MG, Ferreira TM, Leite EL, Toma L, Dietrich CP, Nader HB.
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Mar 05; 119(3):539-47. PubMed ID: 9734337
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy.
    Nader HB, Porcionatto MA, Tersariol IL, Pinhal MA, Oliveira FW, Moraes CT, Dietrich CP.
    J Biol Chem; 1990 Oct 05; 265(28):16807-13. PubMed ID: 2211596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.